급성 척수 손상 시장 보고서 : 동향, 예측 및 경쟁 분석(-2030년)

Acute Spinal Cord Injury Trends and Forecast

The future of the global acute spinal cord injury market looks promising with opportunities in the hospital and trauma center markets. The global acute spinal cord injury market is expected to reach an estimated $9.6 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are growing awareness towards the benefits of early treatment, rising incidence of acute spinal cord injury, and growing popularity of extreme sports activities across the globe.

A more than 150-page report is developed to help in your business decisions.

Acute Spinal Cord Injury by Segment

The study includes a forecast for the global acute spinal cord injury by type, end use, and region.

Acute Spinal Cord Injury Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Complete Spinal Cord Injury
• Incomplete Spinal Cord Injury

Acute Spinal Cord Injury Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Trauma Centers

Acute Spinal Cord Injury Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Acute Spinal Cord Injury Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies acute spinal cord injury companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the acute spinal cord injury companies profiled in this report include-

• Novartis
• Tenax Therapeutics
• Accure Pharma
• Acorda Therapeutics
• Asterias Biotherapeutics
• Renetx Bio
• Bioarctic
• Biotime
• Invivo Therapeutics
• Kringle Pharma

Acute Spinal Cord Injury Market Insights

Lucintel forecasts that incomplete spinal cord injury (ISCI) will remain the larger segment over the forecast period due to increasing incidence of spinal cord injuries and growing awareness towards treatment of spinal cord injuries.

Within this market, hospital is expected to remain the larger segment due to growing number of inpatient rehabilitation programs at hospitals to deliver comprehensive services to help people.

North America will remain the largest region due to surge in aging population, well-developed healthcare system, and increasing adoption of advanced technologies in the region.

Features of the Global Acute Spinal Cord Injury Market

Market Size Estimates: Acute spinal cord injury market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Acute spinal cord injury market size by type, end use, and region in terms of value ($B).

Regional Analysis: Acute spinal cord injury market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the acute spinal cord injury market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the acute spinal cord injury market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the acute spinal cord injury market size?

Answer: The global acute spinal cord injury market is expected to reach an estimated $9.6 billion by 2030.

Q.2 What is the growth forecast for acute spinal cord injury market?

Answer: The global acute spinal cord injury market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the acute spinal cord injury market?

Answer: The major drivers for this market are growing awareness towards the benefits of early treatment, rising incidence of acute spinal cord injury, and growing popularity of extreme sports activities across the globe.

Q4. What are the major segments for acute spinal cord injury market?

Answer: The future of the acute spinal cord injury market looks promising with opportunities in the hospital and trauma center markets.

Q5. Who are the key acute spinal cord injury market companies?

Answer: Some of the key acute spinal cord injury companies are as follows:

• Novartis
• Tenax Therapeutics
• Accure Pharma
• Acorda Therapeutics
• Asterias Biotherapeutics
• Renetx Bio
• Bioarctic
• Biotime
• Invivo Therapeutics
• Kringle Pharma

Q6. Which acute spinal cord injury market segment will be the largest in future?

Answer: Lucintel forecasts that incomplete spinal cord injury (ISCI) will remain the larger segment over the forecast period due to increasing incidence of spinal cord injuries and growing awareness towards treatment of spinal cord injuries.

Q7. In acute spinal cord injury market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to surge in aging population, well-developed healthcare system, and increasing adoption of advanced technologies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the acute spinal cord injury market by type (complete spinal cord injury and incomplete spinal cord injury), end use (hospitals and trauma centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Acute Spinal Cord Injury Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Acute Spinal Cord Injury Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Acute Spinal Cord Injury Market by Type
  • 3.3.1: Complete Spinal Cord Injury
  • 3.3.2: Incomplete Spinal Cord Injury
• 3.4: Global Acute Spinal Cord Injury Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Trauma Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Acute Spinal Cord Injury Market by Region
• 4.2: North American Acute Spinal Cord Injury Market
  • 4.2.2: North American Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers
• 4.3: European Acute Spinal Cord Injury Market
  • 4.3.1: European Acute Spinal Cord Injury Market by Type: Complete Spinal Cord Injury and Incomplete Spinal Cord Injury
  • 4.3.2: European Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers
• 4.4: APAC Acute Spinal Cord Injury Market
  • 4.4.1: APAC Acute Spinal Cord Injury Market by Type: Complete Spinal Cord Injury and Incomplete Spinal Cord Injury
  • 4.4.2: APAC Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers
• 4.5: ROW Acute Spinal Cord Injury Market
  • 4.5.1: ROW Acute Spinal Cord Injury Market by Type: Complete Spinal Cord Injury and Incomplete Spinal Cord Injury
  • 4.5.2: ROW Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Acute Spinal Cord Injury Market by Type
  • 6.1.2: Growth Opportunities for the Global Acute Spinal Cord Injury Market by End Use
  • 6.1.3: Growth Opportunities for the Global Acute Spinal Cord Injury Market by Region
• 6.2: Emerging Trends in the Global Acute Spinal Cord Injury Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Acute Spinal Cord Injury Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Acute Spinal Cord Injury Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Novartis
• 7.2: Tenax Therapeutics
• 7.3: Accure Pharma
• 7.4: Acorda Therapeutics
• 7.5: Asterias Biotherapeutics
• 7.6: ReNetX Bio
• 7.7: BioArctic
• 7.8: BioTime
• 7.9: InVivo Therapeutics
• 7.10: Kringle Pharma